How a children's COVID vaccine could offer a new normal for schools
The final piece of the school-vaccination puzzle may soon fall into place, with Pfizer's recent announcement that it has developed an effective vaccine for children ages 5-11. But…
The final piece of the school-vaccination puzzle may soon fall into place, with Pfizer's recent announcement that it has developed an effective vaccine for children ages 5-11. But…